Notes / Company

Ortin Global Ltd.

ORTINGLOBE BSE 539287 ISIN INE749B01020 Pharmaceuticals

Fundamentals

Market cap: ₹14.03 cr
ROE: 0.00%
Debt / equity: 0.13
52-week range: 11.05 — 21.15

Research on Tijori Finance

Company snapshot

Ortin Global Ltd.

Pharmaceuticals

₹14 cr

Latest quarter · Jun 2012

Sales₹16 cr

Net profit₹0 cr

Op. margin+13.1%

EPS₹0.26

Strength & growth

Debt / equity0.13×

Current ratio2.15×

Sales CAGR−38.8%

The timeline — 1 note on Ortin Global Ltd.

July 2026

11 Jul 26 · 9:11 AM IST Lead

Lead · M&A · Micro cap

Ortin Global's open offer draws just 226 shares of 21.14 lakh target

The acquirer ends up with 1.24% stake instead of the 27.23% control sought. Public shareholders overwhelmingly rejected the ₹14.65 price, aborting the change of control.

Verify on exchange BSE filings for ORTINGLOBE NSE filings for ORTINGLOBE Tijori Finance company page